Description
(Short description)
In den vergangenen Jahrzehnten nahm der Anteil Übergewichtiger besonders unter Kindern und Jugendlichen in vielen Ländern dramatisch zu. Dieser Leitfaden hilft Ärzten und Krankenversicherern, die in einem gegebenen Stadium der Ernährungsstörung wirksamste und gleichzeitig kostengünstigste Therapie auszuwählen. Zahlreiche Tabellen, eine Checkliste zur Qualitätssicherung und ein ausführliches Glossar ergänzen den Text.
(Short description)
Obesity now represents a serious problem in industrialized nations. An increasingly large number of people, especially children, are overweight - leading to subsequent illness and a reduced life expectancy.
At long last, with this first evidence-based review of the current intervention strategies for treating and preventing obesity clinicians and health insurers have a guide that allows them to select the most efficient and cost-effective method of treatment for any given state of the illness. The whole is backed by extensive tables, a checklist for quality assurance and an extensive glossary.
With a foreword by George A. Bray, Boyd Professor at Louisiana State University and Chief of the Clinical Obesity section.
(Table of content)
1. Background
2. Methods - Systematic Review of the Scientific
Evidence
3. Preventing Obesity
4. Treating Obesity in Adults
5. Treating Obesity in Children and Youth
6. Quality of Life
7. Effects of Obesity Treatment on Disease and Special Conditions
8. Economic Assessment of Treatment Methods
9. Ethical Aspects
10. Glossary and Acronyms
(Author portrait)
Dr. Jan Östman, MD, PhD, is Associate Professor of Internal Medicine, Karolinska Institute. Dr. Östman was formerly head of the Center for Metabolism and Endocrinology, Huddinge University Hospital. He is past Chairman of the Swedish Society for Diabetology, and author of about 300 publications, including original articles, reviews, books, and book chapters. Major research topics are regulation of human adipose tissue metabolism, diabetes epidemiology, and transplantation of insulin producing tissue in human diabetes.Dr. Mona Britton, MD, PhD, is Professor of Medicine, Karolinska Institute, Stockholm, Sweden. Dr. Britton is Senior Medical Advisor at the Swedish Council on Technology Assessment in Health Care (SBU), Stockholm.
